Guideng Li

Title: Guideng Li: Innovator in Trogocytosis Mediated Epitope Discovery

Introduction

Guideng Li is a prominent inventor based in Pasadena, CA, known for his significant contributions to the field of immunology. His innovative work focuses on trogocytosis, a process that plays a crucial role in T-cell receptor (TCR) ligand discovery. With a keen interest in advancing scientific knowledge, Li has made strides in developing methods that enhance our understanding of immune responses.

Latest Patents

Guideng Li holds a patent titled "Trogocytosis Mediated Epitope Discovery Methods." This patent discloses various trogocytosis-based TCR ligand discovery platforms and methods. It also includes isolated cells, nucleotides, sequences, and sequence databases produced using these innovative discovery platforms. His work in this area has the potential to revolutionize how we approach immunological research and therapeutic development.

Career Highlights

Li is affiliated with the California Institute of Technology, where he continues to push the boundaries of scientific research. His dedication to innovation is evident in his patent portfolio, which includes 1 patent that showcases his expertise in the field. His work not only contributes to academic knowledge but also has practical implications for medical advancements.

Collaborations

Guideng Li collaborates with esteemed colleagues, including Michael Thomas Bethune and Jocelyn T Kim. These partnerships enhance the research environment and foster the exchange of ideas, leading to groundbreaking discoveries in immunology.

Conclusion

Guideng Li's contributions to trogocytosis mediated epitope discovery exemplify the impact of innovative thinking in science. His work at the California Institute of Technology and his patent on TCR ligand discovery methods highlight his role as a leading inventor in the field. Through collaboration and dedication, Li continues to advance our understanding of immune mechanisms and their applications.